119 related articles for article (PubMed ID: 2391749)
1. [Clinical experience with ceftibuten in complicated urinary tract infections].
Mizutani S; Nishimura K; Yoshimura K; Miyoshi S; Iwao N; Higashimoto J; Shiota K
Jpn J Antibiot; 1990 May; 43(5):779-89. PubMed ID: 2391749
[TBL] [Abstract][Full Text] [Related]
2. [Clinical studies on ceftibuten in the urinary field infection].
Suzuki K; Nagata Y; Horiba M
Jpn J Antibiot; 1990 Nov; 43(11):2003-10. PubMed ID: 2287061
[TBL] [Abstract][Full Text] [Related]
3. [A double blind clinical trial of cefamandole and cefmetazole in complicated urinary tract infections].
Ohkawa M; Hirano S; Nakashima T; Tokunaga S; Motoi I; Kuroda K; Nakamura T; Iwasa Y; Tajika E; Sakai A; Haginaka T; Kanda S; Kato M; Hasegawa M; Mikawa I; Ikeda A; Shoda R; Ejiri S; Takemae K; Kojima A; Nakajima S; Miyagi T; Ohtaki M; Kitagawa K; Kameda K; Taya T; Okumura R; Shimada K; Kobayashi T; Nango C; Okasho A; Fujita Y; Miyazaki K; Tsukahara K; Kawaguchi S; Tanaka T; Ueno K; Watanabe K
Jpn J Antibiot; 1983 Jan; 36(1):129-49. PubMed ID: 6341653
[TBL] [Abstract][Full Text] [Related]
4. [Clinical experience with T-2588 in complicated urinary tract infections].
Fukatsu H; Nonomura H; Ohshita H; Miyagawa Y; Hatano Y; Waki M; Takamura T; Hiraiwa S; Yamada Y; Muramatsu T
Hinyokika Kiyo; 1986 Jul; 32(7):1061-8. PubMed ID: 3776768
[TBL] [Abstract][Full Text] [Related]
5. [Therapeutic efficacy of ceftibuten in chronic respiratory tract infections].
Watanabe A; Oizumi K; Motomiya M; Yoshida T; Ito T; Kanayama H; Saito J; Nakai Y; Sato K
Jpn J Antibiot; 1990 May; 43(5):768-78. PubMed ID: 2391748
[TBL] [Abstract][Full Text] [Related]
6. [Clinical long-term studies on cefuzoname in patients with complicated urinary tract infections].
Nakano N
Jpn J Antibiot; 1987 Apr; 40(4):907-23. PubMed ID: 3613098
[TBL] [Abstract][Full Text] [Related]
7. [Clinical studies of ceftibuten in the field of urology].
Hashimoto H; Yamaguchi S; Yachiku S
Jpn J Antibiot; 1990 Feb; 43(2):355-61. PubMed ID: 2362357
[TBL] [Abstract][Full Text] [Related]
8. [Clinical experience of norfloxacin in urinary tract infection].
Banya Y; Funaki H; Takagane H; Tanji S; Abe T; Aoki H; Kubo T; Ohori T
Hinyokika Kiyo; 1985 Aug; 31(8):1501-17. PubMed ID: 4083210
[TBL] [Abstract][Full Text] [Related]
9. [Clinical trials of flomoxef in complicated urinary tract infections].
Ohta N; Sudoko H; Fukuta K; Nakano M; Ushiyama T; Tajima A; Aso Y; Masuda H; Suzuki A; Suzuki K
Jpn J Antibiot; 1987 Oct; 40(10):1835-44. PubMed ID: 3444025
[TBL] [Abstract][Full Text] [Related]
10. [Morphological response of urinary bacteria to ceftibuten].
Washida H; Sakagami H; Awata S; Kan K; Kawai N; Inuzuka K
Jpn J Antibiot; 1996 Mar; 49(3):273-8. PubMed ID: 8935123
[TBL] [Abstract][Full Text] [Related]
11. Usefulness and problems of the urinary tract infection criteria for evaluating drug efficacy for complicated urinary tract infections.
Arakawa S; Tanaka K; Miura T; Shigemura K; Takenaka A; Matsui T; Kamidono S; Nakano Y; Fujisawa M
J Infect Chemother; 2007 Oct; 13(5):279-84. PubMed ID: 17982714
[TBL] [Abstract][Full Text] [Related]
12. [Clinical studies of ceftazidime in the pediatric field].
Hoshina H; Mikuni K; Ichihashi H
Jpn J Antibiot; 1984 Mar; 37(3):460-8. PubMed ID: 6376855
[TBL] [Abstract][Full Text] [Related]
13. [Long-term treatment and clinical evaluation of enoxacin in complicated urinary tract infections].
Washida H; Sakagami H; Iwase Y; Sasaki S
Hinyokika Kiyo; 1987 Sep; 33(9):1508-12. PubMed ID: 3481218
[TBL] [Abstract][Full Text] [Related]
14. [A clinical evaluation of CS-807 in patients with urinary tract infections].
Nakajima K; Oshinoya Y; Uchibayashi T; Ohkawa M; Hisazumi H
Hinyokika Kiyo; 1988 Aug; 34(8):1515-8. PubMed ID: 3195413
[TBL] [Abstract][Full Text] [Related]
15. [Clinical studies of norfloxacin in urinary tract infections].
Matsuura T; Kurita T
Hinyokika Kiyo; 1985 Nov; 31(11):2085-9. PubMed ID: 4091145
[TBL] [Abstract][Full Text] [Related]
16. [Clinical evaluation of the combination of carumonam and fosfomycin in the treatment of complicated urinary tract infection].
Kakizaki H; Ishii N; Murakami S; Suzuki K; Takamizawa A; Hirano J; Mitobe K; Saito M; Hirano K; Imamura A
Hinyokika Kiyo; 1990 Jun; 36(6):731-5. PubMed ID: 2239570
[TBL] [Abstract][Full Text] [Related]
17. [Clinical long-term studies of the treatment of chronic complicated urinary tract infections. Utility and recurrence after 14-day treatment by cefditoren pivoxil].
Arakawa S; Takagi S; Kamidono S; Kataoka N; Tomioka O; Hazama M; Hirose T; Yamazaki K; Kumamoto Y; Hayashi K
Jpn J Antibiot; 1993 Jan; 46(1):75-94. PubMed ID: 8455334
[TBL] [Abstract][Full Text] [Related]
18. [Clinical evaluation of a new oral cephalosporin, cefprozil, in pediatrics].
Woo M; Higashino H; Kohdera U; Nakamura M; Kawasaki H; Kino M; Kobayashi Y
Jpn J Antibiot; 1992 Dec; 45(12):1635-41. PubMed ID: 1289581
[TBL] [Abstract][Full Text] [Related]
19. [Clinical efficacy of tosufloxacin on the patients with urinary tract infections].
Yoshida K; Kobayashi N; Saitoh H; Negishi T; Yamada T; Watanabe T; Kawakami S; Tari K; Satake I; Ozawa K
Hinyokika Kiyo; 1992 Jan; 38(1):129-34. PubMed ID: 1546562
[TBL] [Abstract][Full Text] [Related]
20. Comparative study of ceftibuten and cefixime in the treatment of complicated urinary tract infections.
Ho MW; Wang FD; Fung CP; Liu CY
J Microbiol Immunol Infect; 2001 Sep; 34(3):185-9. PubMed ID: 11605809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
